Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Vitamin K Antagonists (Vka) Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Vitamin K Antagonists (Vka) Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Vitamin K Antagonists (Vka) Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Vitamin K Antagonists (Vka) Market-Segmentation by Type
5.1 Oral
5.2 Injection
6 Global Vitamin K Antagonists (Vka) Market-Segmentation by Application
6.1 VTE
6.2 ACS/MI
6.3 AF
6.4 Others
7 Global Vitamin K Antagonists (Vka) Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Pfizer
8.1.1 Pfizer Profile
8.1.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.1.4 Pfizer Business Overview/Recent Development/Acquisitions
8.2 Bayer
8.2.1 Bayer Profile
8.2.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Bayer Product/Solution Launches and Enhancements Analysis
8.2.4 Bayer Business Overview/Recent Development/Acquisitions
8.3 Otsuka
8.3.1 Otsuka Profile
8.3.2 Otsuka Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Otsuka Product/Solution Launches and Enhancements Analysis
8.3.4 Otsuka Business Overview/Recent Development/Acquisitions
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Profile
8.4.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
8.4.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.5 AstraZeneca
8.5.1 AstraZeneca Profile
8.5.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.5.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.6 Aspen
8.6.1 Aspen Profile
8.6.2 Aspen Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Aspen Product/Solution Launches and Enhancements Analysis
8.6.4 Aspen Business Overview/Recent Development/Acquisitions
8.7 The Medicines Company
8.7.1 The Medicines Company Profile
8.7.2 The Medicines Company Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 The Medicines Company Product/Solution Launches and Enhancements Analysis
8.7.4 The Medicines Company Business Overview/Recent Development/Acquisitions
8.8 Boehringer Ingelheim
8.8.1 Boehringer Ingelheim Profile
8.8.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.8.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.9 Daiichi Sankyo
8.9.1 Daiichi Sankyo Profile
8.9.2 Daiichi Sankyo Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Daiichi Sankyo Product/Solution Launches and Enhancements Analysis
8.9.4 Daiichi Sankyo Business Overview/Recent Development/Acquisitions
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson Profile
8.10.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.10.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.11 Genentech (Roche)
8.11.1 Genentech (Roche) Profile
8.11.2 Genentech (Roche) Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Genentech (Roche) Product/Solution Launches and Enhancements Analysis
8.11.4 Genentech (Roche) Business Overview/Recent Development/Acquisitions
8.12 Sanofi
8.12.1 Sanofi Profile
8.12.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.12.4 Sanofi Business Overview/Recent Development/Acquisitions
8.13 Lilly
8.13.1 Lilly Profile
8.13.2 Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Lilly Product/Solution Launches and Enhancements Analysis
8.13.4 Lilly Business Overview/Recent Development/Acquisitions
9 Global Vitamin K Antagonists (Vka) Market-Segmentation by Geography
10 North America
10.1 North America Vitamin K Antagonists (Vka) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Vitamin K Antagonists (Vka) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Vitamin K Antagonists (Vka) Production Analysis from 2015-2020
10.4 North America Vitamin K Antagonists (Vka) Consumption Analysis from 2015-2020
10.5 North America Vitamin K Antagonists (Vka) Import and Export from 2015-2020
10.6 North America Vitamin K Antagonists (Vka) Value, Production and Market Share by Type (2015-2020)
10.7 North America Vitamin K Antagonists (Vka) Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Vitamin K Antagonists (Vka) by Country (United States, Canada)
10.8.1 North America Vitamin K Antagonists (Vka) Sales by Country (2015-2020)
10.8.2 North America Vitamin K Antagonists (Vka) Consumption Value by Country (2015-2020)
10.9 North America Vitamin K Antagonists (Vka) Market PEST Analysis
11 Europe
11.1 Europe Vitamin K Antagonists (Vka) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Vitamin K Antagonists (Vka) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Vitamin K Antagonists (Vka) Production Analysis from 2015-2020
11.4 Europe Vitamin K Antagonists (Vka) Consumption Analysis from 2015-2020
11.5 Europe Vitamin K Antagonists (Vka) Import and Export from 2015-2020
11.6 Europe Vitamin K Antagonists (Vka) Value, Production and Market Share by Type (2015-2020)
11.7 Europe Vitamin K Antagonists (Vka) Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Vitamin K Antagonists (Vka) by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Vitamin K Antagonists (Vka) Sales by Country (2015-2020)
11.8.2 Europe Vitamin K Antagonists (Vka) Consumption Value by Country (2015-2020)
11.9 Europe Vitamin K Antagonists (Vka) Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Vitamin K Antagonists (Vka) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Vitamin K Antagonists (Vka) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Vitamin K Antagonists (Vka) Production Analysis from 2015-2020
12.4 Asia-Pacific Vitamin K Antagonists (Vka) Consumption Analysis from 2015-2020
12.5 Asia-Pacific Vitamin K Antagonists (Vka) Import and Export from 2015-2020
12.6 Asia-Pacific Vitamin K Antagonists (Vka) Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Vitamin K Antagonists (Vka) Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Vitamin K Antagonists (Vka) by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Vitamin K Antagonists (Vka) Sales by Country (2015-2020)
12.8.2 Asia-Pacific Vitamin K Antagonists (Vka) Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Vitamin K Antagonists (Vka) Market PEST Analysis
13 Latin America
13.1 Latin America Vitamin K Antagonists (Vka) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Vitamin K Antagonists (Vka) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Vitamin K Antagonists (Vka) Production Analysis from 2015-2020
13.4 Latin America Vitamin K Antagonists (Vka) Consumption Analysis from 2015-2020
13.5 Latin America Vitamin K Antagonists (Vka) Import and Export from 2015-2020
13.6 Latin America Vitamin K Antagonists (Vka) Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Vitamin K Antagonists (Vka) Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Vitamin K Antagonists (Vka) by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Vitamin K Antagonists (Vka) Sales by Country (2015-2020)
13.8.2 Latin America Vitamin K Antagonists (Vka) Consumption Value by Country (2015-2020)
13.9 Latin America Vitamin K Antagonists (Vka) Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Vitamin K Antagonists (Vka) Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Vitamin K Antagonists (Vka) Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Vitamin K Antagonists (Vka) Production Analysis from 2015-2020
14.4 Middle East & Africa Vitamin K Antagonists (Vka) Consumption Analysis from 2015-2020
14.5 Middle East & Africa Vitamin K Antagonists (Vka) Import and Export from 2015-2020
14.6 Middle East & Africa Vitamin K Antagonists (Vka) Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Vitamin K Antagonists (Vka) Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Vitamin K Antagonists (Vka) by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Vitamin K Antagonists (Vka) Sales by Country (2015-2020)
14.8.2 Middle East & Africa Vitamin K Antagonists (Vka) Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Vitamin K Antagonists (Vka) Market PEST Analysis
15 Future Forecast of the Global Vitamin K Antagonists (Vka) Market from 2020-2028
15.1 Future Forecast of the Global Vitamin K Antagonists (Vka) Market from 2020-2028 Segment by Region
15.2 Global Vitamin K Antagonists (Vka) Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Vitamin K Antagonists (Vka) Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
